KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma

John P. Morris, Sam C. Wang, Matthias Hebrok

Research output: Contribution to journalArticle

340 Citations (Scopus)

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is characterized by near-universal mutations in KRAS and frequent deregulation of crucial embryonic signalling pathways, including the Hedgehog (Hh) and Wnt-β-catenin cascades. The creation of mouse models that closely resemble the human disease has provided a platform to better understand when and in which cell types these pathways are misregulated during PDAC development. Here we examine the central part that KRAS plays in the biology of PDAC, and how the timing and location of Hh and Wnt-2-catenin signalling dictate the specification and oncogenic properties of PDAC.

Original languageEnglish (US)
Pages (from-to)683-695
Number of pages13
JournalNature Reviews Cancer
Volume10
Issue number10
DOIs
StatePublished - Oct 2010

Fingerprint

Developmental Biology
Hedgehogs
Adenocarcinoma
Catenins
Mutation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. / Morris, John P.; Wang, Sam C.; Hebrok, Matthias.

In: Nature Reviews Cancer, Vol. 10, No. 10, 10.2010, p. 683-695.

Research output: Contribution to journalArticle

@article{5276fa26111941a1806c322d006e11b9,
title = "KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma",
abstract = "Pancreatic ductal adenocarcinoma (PDAC) is characterized by near-universal mutations in KRAS and frequent deregulation of crucial embryonic signalling pathways, including the Hedgehog (Hh) and Wnt-β-catenin cascades. The creation of mouse models that closely resemble the human disease has provided a platform to better understand when and in which cell types these pathways are misregulated during PDAC development. Here we examine the central part that KRAS plays in the biology of PDAC, and how the timing and location of Hh and Wnt-2-catenin signalling dictate the specification and oncogenic properties of PDAC.",
author = "Morris, {John P.} and Wang, {Sam C.} and Matthias Hebrok",
year = "2010",
month = "10",
doi = "10.1038/nrc2899",
language = "English (US)",
volume = "10",
pages = "683--695",
journal = "Nature Reviews Cancer",
issn = "1474-175X",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma

AU - Morris, John P.

AU - Wang, Sam C.

AU - Hebrok, Matthias

PY - 2010/10

Y1 - 2010/10

N2 - Pancreatic ductal adenocarcinoma (PDAC) is characterized by near-universal mutations in KRAS and frequent deregulation of crucial embryonic signalling pathways, including the Hedgehog (Hh) and Wnt-β-catenin cascades. The creation of mouse models that closely resemble the human disease has provided a platform to better understand when and in which cell types these pathways are misregulated during PDAC development. Here we examine the central part that KRAS plays in the biology of PDAC, and how the timing and location of Hh and Wnt-2-catenin signalling dictate the specification and oncogenic properties of PDAC.

AB - Pancreatic ductal adenocarcinoma (PDAC) is characterized by near-universal mutations in KRAS and frequent deregulation of crucial embryonic signalling pathways, including the Hedgehog (Hh) and Wnt-β-catenin cascades. The creation of mouse models that closely resemble the human disease has provided a platform to better understand when and in which cell types these pathways are misregulated during PDAC development. Here we examine the central part that KRAS plays in the biology of PDAC, and how the timing and location of Hh and Wnt-2-catenin signalling dictate the specification and oncogenic properties of PDAC.

UR - http://www.scopus.com/inward/record.url?scp=77957150824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957150824&partnerID=8YFLogxK

U2 - 10.1038/nrc2899

DO - 10.1038/nrc2899

M3 - Article

VL - 10

SP - 683

EP - 695

JO - Nature Reviews Cancer

JF - Nature Reviews Cancer

SN - 1474-175X

IS - 10

ER -